Thymic carcinoma: A distinct clinical entity responsive to chemotherapy

L. G. Weide, Thomas Ulbright, Patrick Loehrer, S. D. Williams

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Background. Thymic carcinomas are rare tumors of the anterior mediastinum. These tumors are distinct thymic neoplasms that differ from their more common counterpart, thymoma. As opposed to thymomas, thymic carcinomas are histologically malignant neoplasms with a clinical course that tends to be much more aggressive than that of patients with thymoma. Methods. Between 1984 and 1990, five patients with thymic carcinoma treated with cisplatin- based combination chemotherapy were seen at Indiana University Hospital. These patients' diagnoses, courses, and treatments were reviewed. Results. Three patients responded (two completely) to cisplatin-based chemotherapy. Conclusions. This form of chemotherapy merits additional study in such patients, and our experience indicates that at least some will have clinically meaningful responses. The optimum regimen is unclear, but would contain cisplatin and probably should be similar to that used in germ cell tumors.

Original languageEnglish
Pages (from-to)1219-1223
Number of pages5
JournalCancer
Volume71
Issue number4
DOIs
StatePublished - 1993

Fingerprint

Thymoma
Drug Therapy
Cisplatin
Thymus Neoplasms
Neoplasms
Germ Cell and Embryonal Neoplasms
Mediastinum
Combination Drug Therapy

Keywords

  • chemotherapy
  • cisplatin
  • mediastinum
  • thymus

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Thymic carcinoma : A distinct clinical entity responsive to chemotherapy. / Weide, L. G.; Ulbright, Thomas; Loehrer, Patrick; Williams, S. D.

In: Cancer, Vol. 71, No. 4, 1993, p. 1219-1223.

Research output: Contribution to journalArticle

Weide, L. G. ; Ulbright, Thomas ; Loehrer, Patrick ; Williams, S. D. / Thymic carcinoma : A distinct clinical entity responsive to chemotherapy. In: Cancer. 1993 ; Vol. 71, No. 4. pp. 1219-1223.
@article{0332b3c3ea6740a18d2ee50587370c49,
title = "Thymic carcinoma: A distinct clinical entity responsive to chemotherapy",
abstract = "Background. Thymic carcinomas are rare tumors of the anterior mediastinum. These tumors are distinct thymic neoplasms that differ from their more common counterpart, thymoma. As opposed to thymomas, thymic carcinomas are histologically malignant neoplasms with a clinical course that tends to be much more aggressive than that of patients with thymoma. Methods. Between 1984 and 1990, five patients with thymic carcinoma treated with cisplatin- based combination chemotherapy were seen at Indiana University Hospital. These patients' diagnoses, courses, and treatments were reviewed. Results. Three patients responded (two completely) to cisplatin-based chemotherapy. Conclusions. This form of chemotherapy merits additional study in such patients, and our experience indicates that at least some will have clinically meaningful responses. The optimum regimen is unclear, but would contain cisplatin and probably should be similar to that used in germ cell tumors.",
keywords = "chemotherapy, cisplatin, mediastinum, thymus",
author = "Weide, {L. G.} and Thomas Ulbright and Patrick Loehrer and Williams, {S. D.}",
year = "1993",
doi = "10.1002/1097-0142(19930215)71:4<1219::AID-CNCR2820710408>3.0.CO;2-B",
language = "English",
volume = "71",
pages = "1219--1223",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Thymic carcinoma

T2 - A distinct clinical entity responsive to chemotherapy

AU - Weide, L. G.

AU - Ulbright, Thomas

AU - Loehrer, Patrick

AU - Williams, S. D.

PY - 1993

Y1 - 1993

N2 - Background. Thymic carcinomas are rare tumors of the anterior mediastinum. These tumors are distinct thymic neoplasms that differ from their more common counterpart, thymoma. As opposed to thymomas, thymic carcinomas are histologically malignant neoplasms with a clinical course that tends to be much more aggressive than that of patients with thymoma. Methods. Between 1984 and 1990, five patients with thymic carcinoma treated with cisplatin- based combination chemotherapy were seen at Indiana University Hospital. These patients' diagnoses, courses, and treatments were reviewed. Results. Three patients responded (two completely) to cisplatin-based chemotherapy. Conclusions. This form of chemotherapy merits additional study in such patients, and our experience indicates that at least some will have clinically meaningful responses. The optimum regimen is unclear, but would contain cisplatin and probably should be similar to that used in germ cell tumors.

AB - Background. Thymic carcinomas are rare tumors of the anterior mediastinum. These tumors are distinct thymic neoplasms that differ from their more common counterpart, thymoma. As opposed to thymomas, thymic carcinomas are histologically malignant neoplasms with a clinical course that tends to be much more aggressive than that of patients with thymoma. Methods. Between 1984 and 1990, five patients with thymic carcinoma treated with cisplatin- based combination chemotherapy were seen at Indiana University Hospital. These patients' diagnoses, courses, and treatments were reviewed. Results. Three patients responded (two completely) to cisplatin-based chemotherapy. Conclusions. This form of chemotherapy merits additional study in such patients, and our experience indicates that at least some will have clinically meaningful responses. The optimum regimen is unclear, but would contain cisplatin and probably should be similar to that used in germ cell tumors.

KW - chemotherapy

KW - cisplatin

KW - mediastinum

KW - thymus

UR - http://www.scopus.com/inward/record.url?scp=0027392757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027392757&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19930215)71:4<1219::AID-CNCR2820710408>3.0.CO;2-B

DO - 10.1002/1097-0142(19930215)71:4<1219::AID-CNCR2820710408>3.0.CO;2-B

M3 - Article

C2 - 8435796

AN - SCOPUS:0027392757

VL - 71

SP - 1219

EP - 1223

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 4

ER -